Kamada Ltd.
Kamada Ltd. (NASDAQ: KMDA) is trading at $8.72, about ₹836 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, down 1.25% today. Indian residents can buy Kamada from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$8.71
Today's high
$8.81
52 week low
$6.50
52 week high
$9.35
KMDA opened at $8.79, closed previously at $8.83, and has traded between $6.50 and $9.35 over the past 52 weeks.
About
Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its proprietary product segment and its distribution division. Its own manufactured portfolio includes KAMRAB/KEDRAB for rabies prevention, CYTOGAM to prevent cytomegalovirus disease in transplant recipients, WINRHO SDF for immune thrombocytopenic purpura and Rhesus (Rh) isoimmunization, HEPAGAM B for hepatitis B recurrence prevention following liver transplants and for post-exposure prophylaxis, VARIZIG for post-exposure chickenpox prophylaxis, and GLASSIA for intravenous alpha-1 antitrypsin deficiency (AATD). Kamada also produces KamRho (D) for the prophylaxis of hemolytic disease of newborns and immune thrombocytopenic purpura, along with a specific antiserum for Vipera palaestinae and Echis coloratus snake bites. Additionally, the company distributes a wide array of third-party pharmaceutical products, encompassing treatments like BRAMITOB for chronic pulmonary infections, FOSTER for asthma, PROVOCHOLINE for diagnosing bronchial airway hyperactivity, and specialized therapies such as IVIG for immunodeficiency, VARITECT for chickenpox and zoster herpes, and various factors for hemophilia A and B, among numerous others for conditions like hepatitis B, cytomegalovirus, angioedema, Japanese encephalitis, and prostate cancer. Kamada markets its offerings in the United States through strategic partners and internationally via a network of distributors. The company maintains significant collaborations with Takeda Pharmaceuticals Company Limited, PARI GmbH, and Kedrion Biopharma. Established in 1990, Kamada Ltd. is headquartered in Rehovot, Israel.
Key statistics
Avg. volume
91.25K
Market cap
$503.09M
P/E Ratio
22.77
Price-to-sales ratio
2.62
Enterprise value
$485.42M
Free cash flow yield
5.26%
Debt-to-equity ratio
0.04
Return on equity
8.37%
ROIC
6.90%
Beta
0.14
Dividend yield
4.82%
Last dividend
$0.42
Financial overview
Revenue
$180.46M
Earnings per share
$0.38
Free cash flow
$16.93M
Net profit margin
11.60%
Gross margin
40.82%
EBITDA
$39.25M
Revenue growth
12.12%
Similar securities
This is not an investment recommendation
How to buy Kamada from India
Indian residents can buy Kamada shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Kamada and place an order
Find Kamada by name or by its ticker, KMDA, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Kamada trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Kamada position in USD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Kamada from India
Trading and taxes when buying Kamada from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Kamada’s current yield is 4.82%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Kamada stock?
Yes. Kamada (KMDA) has been listed on NASDAQ since 2013, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Kamada share cost in rupees?
One Kamada share is $8.72 — about ₹836 at a USD/INR rate of 95.88 on 26 Sep 2026. Both the Kamada price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Kamada from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Kamada?
Yes. One Kamada share is $8.72, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Kamada.
How are gains on Kamada shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Kamada price. Paasa issues a capital-gains statement for your return.
Does Kamada pay a dividend, and how is it taxed in India?
Yes. Kamada pays a dividend and the current yield is 4.82%; the last declared dividend was $0.42 per share, about ₹40.27. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Kamada from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is Kamada a United States company, and does that change how it is taxed?
Kamada trades on NASDAQ in US dollars, but the company is domiciled in Israel. Kamada trades as an ordinary share listed directly in the US, not a depositary receipt. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare Kamada shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Kamada holding, its cost and its closing value.
How do I sell Kamada and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.